Technical Analysis for KNTE - Kinnate Biopharma Inc.

Grade Last Price % Change Price Change
D 38.3 -4.25% -1.70
KNTE closed down 4.25 percent on Friday, January 15, 2021, on 27 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Flat
Historical KNTE trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Narrow Range Bar Range Contraction -4.25%
NR7 Range Contraction -4.25%
Up 3 Days in a Row Strength -4.25%
Up 4 Days in a Row Strength -4.25%
Up 5 Days in a Row Strength -4.25%
Narrow Range Bar Range Contraction -3.53%
Inside Day Range Contraction -3.53%
Older End-of-Day Signals for KNTE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors for treating genomically defined cancers. The company's lead product candidate is KIN002787, which is a rapidly accelerated fibrosarcoma inhibitor that is in preclinical stage for the treatment of patients with lung cancer, melanoma, and other solid tumors. Its other products in preclinical stage include KIN003, which are small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors (FGFR)2 and FGFR3 genes; and small molecule research programs, including a Cyclin-Dependent Kinase 12 inhibitor in its KIN004 program. Kinnate Biopharma Inc. was founded in 2018 and is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Solid Tumors Melanoma Sarcoma Lung Cancer Fibroblast Growth Factor Fibroblast Growth Factor Receptor

Is KNTE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 48.75
52 Week Low 34.14
Average Volume 273,974
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 38.38
10-Day Moving Average 38.12
Average True Range 2.91
ADX 12.41
+DI 16.69
-DI 20.20
Chandelier Exit (Long, 3 ATRs ) 33.68
Chandelier Exit (Short, 3 ATRs ) 42.86
Upper Bollinger Band 40.85
Lower Bollinger Band 35.91
Percent B (%b) 0.48
BandWidth 12.88
MACD Line -0.71
MACD Signal Line -0.96
MACD Histogram 0.2402
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.31
Resistance 3 (R3) 41.56 40.80 40.81
Resistance 2 (R2) 40.80 40.04 40.68 40.64
Resistance 1 (R1) 39.55 39.56 39.18 39.30 40.47
Pivot Point 38.80 38.80 38.61 38.67 38.80
Support 1 (S1) 37.55 38.03 37.17 37.30 36.13
Support 2 (S2) 36.79 37.56 36.67 35.96
Support 3 (S3) 35.54 36.79 35.79
Support 4 (S4) 35.29